Oncology
3 drugs are in development for Neoplasms.
- Companies
- 3
- Clinical trials
- 37
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Neoplasms pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
About this indication
Neoplasms context
Oncology·MeSH: Neoplasms (D009369)
Also known as: Neoplasia, Neoplasias, Neoplasm, Tumor, Tumors
Narrower concepts tracked separately: Malignant Neoplasm, Cancer
Prevalence
287.0 / 100K
Incidence
128.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Neoplasms?
BioSniper tracks 3 drugs in development for Neoplasms across 3 companies.
How many clinical trials target Neoplasms?
There are 37 clinical trials targeting Neoplasms tracked by BioSniper.
What is the prevalence of Neoplasms?
The estimated prevalence of Neoplasms is approximately 287.0 per 100,000 population.